Data for ST002615
Metabolite structure | All data | F1 | F2 | F3 | F4 | F5 | F6 | F7 | F8 | F9 | F10 | F11 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
5^-methylthioadenosine | 1.72 | 1.53 | 3.06 | 1.87 | 1.84 | 2.13 | 1.98 | 2.37 | 1.79 | 1.96 | 1.61 | |
adenine | 23.94 | 26.04 | 26.71 | 22.68 | 25.73 | 24.32 | 24.21 | 27.32 | 24.34 | 26.96 | 24.50 | |
ADP | 836.09 | 1267.87 | 1194.49 | 858.00 | 1221.69 | 948.39 | 1105.56 | 871.39 | 1264.38 | 952.77 | 1346.40 | |
ADP-ribose | 18.47 | 21.88 | 78.47 | 22.19 | 18.38 | 21.21 | 15.05 | 21.69 | 17.05 | 17.05 | 18.98 | |
AICAR | 0.06 | 0.06 | 0.10 | 0.10 | 0.04 | 0.10 | 0.06 | 0.05 | 0.03 | 0.07 | 0.05 | |
AMP | 1262.61 | 1594.26 | 2451.37 | 1223.06 | 1022.21 | 1434.18 | 746.79 | 773.63 | 804.51 | 789.21 | 1339.56 | |
ATP | 1019.49 | 2787.65 | 1130.10 | 1185.16 | 2803.44 | 1147.54 | 2228.26 | 1532.63 | 2751.08 | 1797.02 | 2747.56 | |
CDP | 5.01 | 6.97 | 4.44 | 5.55 | 6.39 | 5.52 | 5.89 | 6.46 | 6.16 | 5.35 | 6.32 | |
CMP | 12.15 | 17.25 | 27.11 | 12.94 | 14.63 | 13.77 | 12.78 | 10.69 | 14.54 | 12.89 | 15.40 | |
CTP | 9.87 | 23.20 | 4.25 | 12.44 | 31.96 | 9.83 | 24.14 | 17.72 | 27.51 | 19.59 | 22.54 | |
dATP | 0.11 | 0.27 | 0.17 | 0.14 | 0.32 | 0.12 | 0.24 | 0.17 | 0.32 | 0.19 | 0.31 | |
dCTP | 0.54 | 0.97 | 0.58 | 0.66 | 1.24 | 0.61 | 1.03 | 0.68 | 1.15 | 0.66 | 1.10 | |
dTTP | 0.11 | 0.13 | 0.09 | 0.15 | 0.18 | 0.13 | 0.15 | 0.14 | 0.16 | 0.18 | 0.15 | |
GDP | 82.91 | 140.72 | 86.12 | 89.13 | 121.17 | 98.47 | 111.86 | 87.99 | 128.67 | 80.59 | 127.21 | |
GDP-mannose | 40.88 | 33.82 | 36.96 | 42.64 | 33.23 | 38.47 | 32.56 | 49.38 | 35.93 | 52.56 | 37.31 | |
GMP | 204.39 | 283.47 | 358.98 | 187.80 | 268.47 | 230.85 | 197.01 | 156.30 | 249.00 | 176.45 | 264.99 | |
GTP | 91.95 | 255.55 | 41.68 | 117.04 | 266.80 | 107.46 | 225.93 | 145.96 | 262.25 | 166.05 | 233.30 | |
guanine | 0.45 | 0.43 | 0.92 | 0.53 | 0.24 | 0.54 | 0.29 | 0.43 | 0.25 | 0.23 | 0.44 | |
guanosine | 3.39 | 4.42 | 13.41 | 3.54 | 2.20 | 4.30 | 2.60 | 2.32 | 2.11 | 2.20 | 2.73 | |
hypoxanthine | 10.64 | 25.29 | 47.65 | 15.14 | 5.58 | 11.53 | 9.31 | 12.22 | 7.07 | 15.14 | 37.23 | |
IMP | 313.30 | 708.33 | 327.66 | 338.48 | 795.62 | 434.78 | 585.48 | 328.54 | 761.28 | 433.95 | 635.58 | |
NAD+ | 740.49 | 760.52 | 868.52 | 743.37 | 766.21 | 727.02 | 696.59 | 741.54 | 742.18 | 768.76 | 739.00 | |
NADH | 62.74 | 23.55 | 39.72 | 66.55 | 33.61 | 56.50 | 42.12 | 58.45 | 32.25 | 57.12 | 37.87 | |
NADP+ | 160.33 | 219.49 | 285.77 | 141.48 | 171.93 | 148.09 | 182.80 | 142.87 | 171.80 | 151.75 | 193.72 | |
NADPH | 227.39 | 162.47 | 133.76 | 243.87 | 233.56 | 230.19 | 235.76 | 275.20 | 245.60 | 252.99 | 192.49 | |
NaMN | 0.13 | 0.15 | 0.25 | 0.12 | 0.14 | 0.10 | 0.18 | 0.06 | 0.11 | 0.09 | 0.23 | |
NMN | 5.09 | 9.46 | 10.37 | 4.92 | 6.86 | 4.94 | 6.15 | 5.76 | 5.31 | 5.87 | 9.82 | |
PRPP | 0.52 | 1.09 | 0.49 | 0.67 | 1.10 | 0.50 | 1.08 | 0.59 | 1.10 | 0.74 | 1.19 | |
S-adenosylhomocysteine | 18.67 | 12.38 | 26.22 | 17.42 | 10.18 | 24.51 | 12.06 | 18.18 | 11.40 | 18.61 | 15.11 | |
S-AMP | 39.48 | 33.46 | 69.85 | 41.21 | 17.52 | 44.93 | 25.66 | 22.77 | 23.21 | 25.44 | 31.06 | |
UDP | 53.35 | 62.80 | 25.07 | 66.69 | 61.44 | 63.56 | 73.26 | 75.02 | 66.50 | 62.35 | 69.10 | |
UDP-galactose | 438.88 | 638.55 | 613.01 | 441.01 | 582.27 | 507.45 | 592.54 | 460.44 | 586.97 | 476.31 | 575.76 | |
UMP | 228.67 | 223.08 | 508.56 | 220.59 | 150.04 | 248.84 | 176.28 | 160.63 | 168.89 | 147.53 | 222.76 | |
UTP | 67.00 | 110.86 | 12.85 | 96.74 | 180.54 | 69.32 | 177.80 | 127.76 | 171.21 | 139.54 | 154.49 | |
XMP | 0.56 | 0.69 | 0.49 | 0.64 | 0.48 | 0.51 | 0.49 | 0.51 | 0.50 | 0.56 | 0.70 | |
ZMP | 0.86 | 0.34 | 0.64 | 1.25 | 0.39 | 1.37 | 0.66 | 1.21 | 0.70 | 1.16 | 0.61 |
Factors:
F1 | Group:Control | Timepoint:8 weeks of training or control time | Sex:Female |
F2 | Group:Control | Timepoint:8 weeks of training or control time | Sex:Male |
F3 | Group:QC-ExternalStandard | Timepoint:0 hour | Sex:- |
F4 | Group:Training | Timepoint:1 week of training or control time | Sex:Female |
F5 | Group:Training | Timepoint:1 week of training or control time | Sex:Male |
F6 | Group:Training | Timepoint:2 weeks of training | Sex:Female |
F7 | Group:Training | Timepoint:2 weeks of training | Sex:Male |
F8 | Group:Training | Timepoint:4 weeks of training | Sex:Female |
F9 | Group:Training | Timepoint:4 weeks of training | Sex:Male |
F10 | Group:Training | Timepoint:8 weeks of training or control time | Sex:Female |
F11 | Group:Training | Timepoint:8 weeks of training or control time | Sex:Male |